Shanxi Guangsheng Medicinal Capsule Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shanxi Guangsheng Medicinal Capsule Co., Ltd. - overview
Established
1983
Location
Jinzhong, Shanxi, China
Primary Industry
Pharmaceuticals
About
Shanxi Guangsheng Medicinal Capsule Co. , Ltd. is a Chinese manufacturer specializing in the production of high-quality medicinal capsules, serving the pharmaceutical and nutraceutical industries with a focus on innovation and efficiency. Founded in 1983 and headquartered in Jinzhong, China, Shanxi Guangsheng Medicinal Capsule Co.
, Ltd. produces various types of capsules used in pharmaceuticals and nutraceuticals. The company does not have publicly known subsidiaries or major pivots in its business strategy. Its CEO, Michael Zhu, leads the organization, which has engaged in one significant deal; in August 2021, Advent International agreed to acquire a majority stake from Meihua Holdings Group Co.
, Ltd. Guangsheng Capsule Co. , Ltd. specializes in manufacturing gelatin capsules, hydroxypropyl methylcellulose (HPMC) plant capsules, and pullulan plant capsules.
They offer customized formulas that do not contain titanium dioxide and provide personalized printing services. The company achieves over 99. 9% production efficiency, serving a diverse clientele in the pharmaceutical, nutraceutical, and dietary supplement industries globally, and emphasizes advanced cold-chain logistics for timely delivery. The company operates primarily through B2B transactions with pharmaceutical and nutraceutical companies, driving revenue from sales of pullulan plant capsules and tailored formulations to wholesalers and retailers.
Pricing negotiations depend on order volumes and specifications, and strategic partnerships, including one with Baonuo-Sandia, enhance its market reach and revenues. Following the acquisition by Advent International in August 2021, which aims to strengthen their position in the healthcare sector in Greater China, Guangsheng Capsule Co. , Ltd. plans to expand its product offerings and enter new markets.
Specific upcoming products and their launch dates have yet to be disclosed. The strategic focus will be on enhancing their presence in both domestic and international markets, utilizing recent funding to support these initiatives.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.gscapsule.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Shanxi Guangsheng Medicinal Capsule Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Announced | Shanxi Guangsheng Medicinal Capsule Co., Ltd. | - |
Displaying 1 - 1 of 1
Shanxi Guangsheng Medicinal Capsule Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.